[{"AccountsPayableCurrent_0_Q1_USD":1934000.0,"ProceedsFromStockOptionsExercised_1_Q1_USD":71000.0,"NetIncomeLossAvailableToCommonStockholdersBasic_1_Q1_USD":570000.0,"LongTermDebtCurrent_0_Q1_USD":8333000.0,"InvestmentIncomeInterest_1_Q1_USD":298000.0,"IncrementalCommonSharesAttributableToCallOptionsAndWarrants_1_Q1_shares":27000.0,"DeferredRentCreditNoncurrent_0_Q1_USD":54000.0,"CommonStockValueOutstanding_0_Q1_USD":17000.0,"ComprehensiveIncomeNetOfTax_1_Q1_USD":570000.0,"OtherAccruedLiabilitiesCurrent_0_Q1_USD":1855000.0,"WeightedAverageNumberOfSharesOutstandingBasic_1_Q1_shares":17372000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_0_Q1_USD":42704000.0,"EarningsPerShareDiluted_1_Q1_USD":0.03,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_1_Q1_shares":169200.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_0_Q1_shares":716040.0,"SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1_0_Q1_USD":19643000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant_0_Q1_shares":1562672.0,"OtherAssetsNoncurrent_0_Q1_USD":216000.0,"LongTermDebtNoncurrent_0_Q1_USD":17013000.0,"EarningsPerShareBasic_1_Q1_USD":0.03,"CostOfGoodsAndServicesSold_1_Q1_USD":2391000.0,"CapitalExpendituresIncurredButNotYetPaid_1_Q1_USD":270000.0,"ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_1_Q1_USD":31.05,"ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_1_Q1_USD":2.16,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_0_Q1_USD":14.46,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_0_Q1_USD":2.38,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_0_Q1_shares":2762364.0,"SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares_0_Q1_shares":111571.0,"AccountsReceivableNetNoncurrent_0_Q1_USD":756000.0,"StockIssuedDuringPeriodValueEmployeeStockPurchasePlan_1_Q1_USD":603000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized_1_Q1_shares":856545.0,"RevenueFromContractWithCustomerExcludingAssessedTax_1_Q1_USD":17418000.0,"ProceedsFromStockPlans_1_Q1_USD":488000.0,"PreferredStockValueOutstanding_0_Q1_USD":0.0,"OtherSundryLiabilitiesCurrent_0_Q1_USD":274000.0,"NumberOfOperatingSegments_1_Q1_segment":1.0,"IncomeLossAttributableToParent_1_Q1_USD":570000.0,"EmbeddedDerivativeGainLossOnEmbeddedDerivativeNet_1_Q1_USD":0.0,"ContractWithCustomerPerformanceObligationSatisfiedInPreviousPeriod_1_Q1_USD":3160000.0,"CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_1_Q1_USD":-192000.0,"SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue_0_Q1_USD":2.39,"AmortizationOfFinancingCostsAndDiscounts_1_Q1_USD":224000.0,"AccruedEmployeeBenefitsCurrent_0_Q1_USD":103000.0,"AccruedBonusesCurrentAndNoncurrent_0_Q1_USD":1794000.0,"IncrementalCommonSharesAttributableToShareBasedPaymentArrangements_1_Q1_shares":1310000.0,"IncreaseDecreaseInEmployeeRelatedLiabilities_1_Q1_USD":-2645000.0,"RepaymentsOfLongTermLinesOfCredit_1_Q1_USD":0.0,"EmployeeRelatedLiabilitiesCurrent_0_Q1_USD":3134000.0,"AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition_1_Q1_USD":1577000.0,"AllocatedShareBasedCompensationExpense_1_Q1_USD":1577000.0,"IncreaseDecreaseInOtherOperatingAssets_1_Q1_USD":77000.0,"CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_0_Q1_USD":98653000.0,"ProceedsFromShortTermDebt_1_Q1_USD":0.0,"AccruedRoyaltiesCurrent_0_Q1_USD":92000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice_1_Q1_USD":26.59,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod_1_Q1_shares":12200.0,"OtherNonoperatingIncomeExpense_1_Q1_USD":0.0,"PaymentsToAcquirePropertyPlantAndEquipment_1_Q1_USD":500000.0,"NetIncomeLoss_1_Q1_USD":570000.0,"NetCashProvidedByUsedInOperatingActivities_1_Q1_USD":-251000.0,"NetCashProvidedByUsedInInvestingActivities_1_Q1_USD":-500000.0,"NetCashProvidedByUsedInFinancingActivities_1_Q1_USD":559000.0,"LiabilitiesCurrent_0_Q1_USD":15256000.0,"LiabilitiesAndStockholdersEquity_0_Q1_USD":120257000.0,"Liabilities_0_Q1_USD":32323000.0,"InventoryNet_0_Q1_USD":1219000.0,"IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_1_Q1_USD":129000.0,"IncreaseDecreaseInAccountsReceivable_1_Q1_USD":-161000.0,"PrepaidExpenseAndOtherAssetsCurrent_0_Q1_USD":2080000.0,"IncreaseDecreaseInAccountsPayable_1_Q1_USD":56000.0,"GrossProfit_1_Q1_USD":15027000.0,"Depreciation_1_Q1_USD":91000.0,"CommonStockSharesOutstanding_0_Q1_shares":17203496.0,"CommonStockSharesIssued_0_Q1_shares":17203496.0,"CashAndCashEquivalentsAtCarryingValue_0_Q1_USD":98653000.0,"AssetsCurrent_0_Q1_USD":116552000.0,"Assets_0_Q1_USD":120257000.0,"AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_1_Q1_shares":969000.0,"AdditionalPaidInCapital_0_Q1_USD":139559000.0,"AccruedIncomeTaxesCurrent_0_Q1_USD":79000.0,"AccountsReceivableNetCurrent_0_Q1_USD":14600000.0,"IncomeTaxExpenseBenefit_1_Q1_USD":0.0,"PropertyPlantAndEquipmentNet_0_Q1_USD":2733000.0,"RetainedEarningsAccumulatedDeficit_0_Q1_USD":-51642000.0,"StockholdersEquity_0_Q1_USD":87934000.0,"FairValueAdjustmentOfWarrants_1_Q1_USD":0.0,"AccruedProfessionalFeesCurrent_0_Q1_USD":1123000.0,"PropertyPlantAndEquipmentGross_0_Q1_USD":4026000.0,"IncreaseDecreaseInInventories_1_Q1_USD":-19000.0,"AmortizationOfIntangibleAssets_1_Q1_USD":0.0,"AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_0_Q1_USD":1293000.0,"WeightedAverageNumberOfDilutedSharesOutstanding_1_Q1_shares":18734000.0,"StockIssuedDuringPeriodValueStockOptionsExercised_1_Q1_USD":71000.0,"StockIssuedDuringPeriodSharesStockOptionsExercised_1_Q1_shares":32602.0,"ShareBasedCompensation_1_Q1_USD":1577000.0,"SellingGeneralAndAdministrativeExpense_1_Q1_USD":11078000.0,"ResearchAndDevelopmentExpense_1_Q1_USD":2913000.0,"PreferredStockSharesOutstanding_0_Q1_shares":0.0,"PreferredStockSharesIssued_0_Q1_shares":0.0,"PreferredStockSharesAuthorized_0_Q1_shares":10000000.0,"PreferredStockParOrStatedValuePerShare_0_Q1_USD":0.001,"OperatingIncomeLoss_1_Q1_USD":1036000.0,"OperatingExpenses_1_Q1_USD":13991000.0,"InterestPayableCurrent_0_Q1_USD":184000.0,"InterestExpense_1_Q1_USD":764000.0,"IncreaseDecreaseInOtherAccruedLiabilities_1_Q1_USD":-96000.0,"CommonStockSharesAuthorized_0_Q1_shares":200000000.0,"CommonStockParOrStatedValuePerShare_0_Q1_USD":0.001,"CommitmentsAndContingencies_0_Q1_USD":null,"AllowanceForDoubtfulAccountsReceivable_0_Q1_USD":0.0,"TemporaryEquityAccretionToRedemptionValueAdjustment_1_Q1_USD":0.0,"TemporaryEquityDividendsAdjustment_1_Q1_USD":0.0,"Ticker":"CSTL","CIK":"1447362","name":"CASTLE BIOSCIENCES INC","OfficialName":"Castle Biosciences Inc. Common Stock","form":"10-Q","period":"20200331","fy":"2020.0","fp":"Q1","qtrs":"0","uom":"USD","footnote":"nan","Market Cap":"617985841.0","Country":"United States","Sector":"Health Care","Industry":"Medical Specialities","Market":"NASDAQ","SP500":"nan","filed":"20200511"}]